PIOLAX, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,207 JPY | +0.32% |
|
+0.36% | -5.28% |
| 2023 | PIOLAX, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
| 2022 | Tranche Update on PIOLAX, Inc.'s Equity Buyback Plan announced on November 9, 2021. | CI |
ETFs positioned on PIOLAX, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.29% | 11 M€ | +16.03% | ||
| 0.01% | 17 M€ | +15.30% | - | |
| 0.01% | 20,360 M€ | +17.02% | - | |
| 0.01% | 140,441 M€ | +18.10% | ||
| 0.01% | 63,295 M€ | +18.14% | - | |
| 0.00% | 746 M€ | -.--% | - | |
| 0.00% | 32 M€ | +1.29% | - | |
| 0.00% | 10 M€ | -3.35% | - |
PIOLAX, INC. is a Japan-based company principally engaged in the manufacture and sale of automotive related products. The Company operates in two business segments. Automotive Related Business segment is mainly involved in the manufacture and sale of precision springs, industrial fasteners, as well as small unit parts that combine resin and metal to the automobile industry. Medical Equipment Business segment is involved in the manufacture and sale of interventional radiology (IVR), endoscopic treatment, and orthopedic treatment equipment to medical institutions.
Calendar
2024-08-05
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
2,200
JPY
Average target price
2,365
JPY
Spread / Average Target
+7.50%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -5.28% | 477M | |
| +19.06% | 47.07B | |
| -7.99% | 22.46B | |
| +15.03% | 18.68B | |
| +26.99% | 16.09B | |
| -6.75% | 14.6B | |
| -19.24% | 13.24B | |
| -20.00% | 13.03B | |
| +40.16% | 11.79B | |
| +40.88% | 11.43B |
- Stock Market
- Equities
- 5988 Stock
- Funds and ETFs PIOLAX, Inc.
